Shilpa Medicare rallies as subsidiary gets European regulator’s nod for blood pressure drug

Share it

Shilpa Medicare shares rose over 6% after its subsidiary received European Directorate for the Quality of Medicines certification.

Leave a Comment

Your email address will not be published. Required fields are marked *